176
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Does Maternal Vitamin D Level Affect the Ovarian Reserve of Female Newborn Infants?

ORCID Icon, , , , , & show all
Pages 987-995 | Received 06 May 2022, Accepted 10 Jun 2022, Published online: 26 Jun 2022

References

  • Reichetzeder C, Chen H, Föller M, Slowinski T, Jian L, Chen YP, Lang F, Hocher B. Maternal vitamin D deficiency and fetal programming - lessons learned from humans and mice. Kidney Blood Press Res. 2014;39(4):315–29. doi:10.1159/000355809.
  • Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. Bjog. 2010;117(13):1593–8. doi:10.1111/j.1471-0528.2010.02742.x.
  • Wei SQ. Vitamin D and pregnancy outcomes. Curr Opin Obstet Gynecol. 2014;26(6):438–47. doi:10.1097/gco.0000000000000117.
  • Dror DK. Vitamin D status during pregnancy: maternal, fetal, and postnatal outcomes. Curr Opin Obstet Gynecol. 2011;23(6):422–6. doi:10.1097/gco.0b013e32834cb791.
  • Geber S, Megale R, Vale F, Lanna AM, Cabral ACV. Variation in ovarian follicle density during human fetal development. J Assist Reprod Genet. 2012;29(9):969–72. doi:10.1007/s10815-012-9810-2.
  • de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357–62. doi:10.1016/S0015-0282(01)02993-4.
  • Durlinger AL, Kramer P, Karels B, Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999;140(12):5789–96. doi:10.1210/endo.140.12.7204.
  • Xu J, Xu F, Lawson MS, Tkachenko OY, Ting AY, Kahl CA, Park BS, Stouffer RR, Bishop CV. Anti-Müllerian hormone is a survival factor and promotes the growth of rhesus macaque preantral follicles during matrix-free culture. Biol Reprod. 2018;98(2):197–207. doi:10.1093/biolre/iox181.
  • Lata I, Tiwari S, Gupta A, Yadav S, Yadav S. To study the vitamin D levels in infertile females and correlation of vitamin D deficiency with AMH levels in comparison to fertile females. J Hum Reprod Sci. 2017;10(2):86–90. doi:10.4103/jhrs.JHRS_105_16.
  • Naderi Z, Kashanian M, Chenari L, Sheikhansari N. Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women. Gynecol Endocrinol. 2018;34(5):409–12. doi:10.1080/09513590.2017.1410785.
  • Jukic AM, Wilcox AJ, Weinberg CR, Baird DD, Steiner AZ. 25-Hydroxyvitamin D (25(OH)D) and biomarkers of ovarian reserve. Menopause. 2018;25(7):811–6. doi:10.1097/GME.0000000000001075.
  • Dennis NA, Houghton LA, Pankhurst MW, Harper MJ, McLennan IS. Acute supplementation with high dose vitamin D3 increases serum anti-Müllerian hormone in young women. Nutrients. 2017;9(7):719. doi:10.3390/nu9070719.
  • Hawes JE, Tesic D, Whitehouse AJ, Zosky GR, Smith JT, Wyrwoll CS. Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse. Behav Brain Res. 2015;286:192–200. doi:10.1016/j.bbr.2015.03.008.
  • Gur EB, Gur MS, Ince O, Kasap E, Genc M, Tatar S, Bugday S, Turan GA, Guclu S. Vitamin D deficiency in pregnancy may affect fetal thymus development. Ginekol Pol. 2016;87(5):378–83. doi: 10.5603/GP.2016.0008
  • Maia-Ceciliano TC, Barreto-Vianna AR, Barbosa-da-Silva S, Aguila MB, Faria TS, Mandarim-de-Lacerda CA. Maternal vitamin D-restricted diet has consequences in the formation of pancreatic islet/insulin-signaling in the adult offspring of mice. Endocrine. 2016;54(1):60–9. doi:10.1007/s12020-016-0973-y.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. doi:10.1210/jc.2011-0385.
  • Chango A, Pogribny IP. Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome. Nutrients. 2015;7(4):2748–70. doi:10.3390/nu7042748.
  • Ideraabdullah FY, Belenchia AM, Rosenfeld CS, Kullman SW, Knuth M, Mahapatra D, Bereman M, Levin ED, Peterson CA. Maternal vitamin D deficiency and developmental origins of health and disease (DOHaD). J Endocrinol. Author manuscript; available in PMC 2020; Published before final editing as: J Endocrinol. 2019 Mar 1: JOE-18-0541.R2. Published online. 2019;241(2):R65–R80. doi: 10.1530/JOE-18-0541
  • Anderson CM, Gillespie SL, Thiele DK, Ralph JL, Ohm JE. Effects of maternal vitamin D supplementation on the maternal and infant epigenome. Breastfeed Med. 2018;13(5):371–80. doi:10.1089/bfm.2017.0231.
  • Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2013;92(2):128–39. doi:10.1007/s00223-012-9607-4.
  • Rostami M, Simbar M, Amiri M, Bidhendi-Yarandi R, Hosseinpanah F, Ramezani Tehrani F. The optimal cut-off point of vitamin D for pregnancy outcomes using a generalized additive model. Clin Nutr. 2021;40(4):2145–53. doi:10.1016/j.clnu.2020.09.039.
  • Baki Yildirim S, Koşar Can Ö. An investigation of vitamin D deficiency in pregnant women and their infants in Giresun province located in the Black Sea region of Turkey. J Obstet Gynaecol. 2019;39(4):498–503. Epub 2019 Feb 16. doi:10.1080/01443615.2018.1539469.
  • Gür G, Abaci A, Köksoy AY, Anik A, Catli G, Fatih Kişlal M, Akin KO, Andiran N. Incidence of maternal vitamin D deficiency in a region of Ankara, Turkey: a preliminary study. Turk J Med Sci. 2014;44(4):616–23. doi:10.3906/sag-1304-107.
  • Hagen CP, Aksglaede L, Sørensen K, Mouritsen A, Juul A. Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges. Pediatr Endocrinol Rev. 2011;9(S1):525–8.
  • Moridi I, Chen A, Tal O, Tal R. The Association between vitamin D and Anti-müllerian hormone. A systemic review and meta-analysis. Nutrients. 2020; 12(6):1567. doi:10.3390/nu12061567.
  • Detti L, Christiansen ME, Francillon L, Ikuwezunma G, Diamond MP, Mari G, Tobiasz AM. Serum anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses. Syst Biol Reprod Med. 2019;65(2):147–54. doi:10.1080/19396368.2018.1537385.
  • Kollmann M, Obermayer-Pietsch B, Lerchbaum E, Lang U, Herzog SA, Trummer C, Scheuchenegger A, Ulrich D, Klaritsch P. Androgen and anti-Mullerian hormone concentrations at term in newborns and their mothers with and without polycystic ovary syndrome. JCM. 2019;8(11):1817. doi:10.3390/jcm8111817.
  • Caanen MR, Kuijper EA, Hompes PG, Kushnir MM, Rockwood AL, Meikle WA, Homburg R, Lambalk CB. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome. Eur J Endocrinol. 2016;174(1):25–32. doi:10.1530/EJE-15-0699.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.